Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Progesterone for Neuroprotection in Infants with CHD
NCT02133573Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jul 2014
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of Crinone in neurodevelopmental disorder (NDD), white matter injury (WMI), periventricular leukomalacia (PVL), sponsored by Children's Hospital of Philadelphia. Started Jul 2014; status: completed.
02
Drugs
Crinone
03
Conditions
neurodevelopmental disorder (NDD)white matter injury (WMI)periventricular leukomalacia (PVL)
Beyond the preview
Go deeper on NCT02133573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133573.